Big Cypress Acquisition (BCYP) executive Erickson received 232,642 units

Insider transactions reported

Bruce Kipp Erickson (executive at Big Cypress Acquisition Corp., BCYP) reported that they received 232,642 units on Oct 22, 2021.

Reporting person

Erickson Bruce Kipp

Options and other derivatives

Holdings before and after

• Employee Stock Option (right to buy): 0 to 232,642 direct

Footnotes from the filing

1. 1. Pursuant to the Agreement and Plan of Merger, dated June 21, 2021 and as amended August 12, 2021 (the Business Combination Agreement ), by and among Big Cypress Acquisition Corp. ( BCYP ), Big Cypress Merger Sub Inc., and SAB Biotherapeutics, Inc. ( Old SAB Biotherapeutics ), each security to purchase shares of Old SAB Biotherapeutics common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a conversion rate of $10.10. Upon consummation of the business combination, BCYP changed its name to SAB Biotherapeutics, Inc. ( New SAB Biotherapeutics or Issuer ).
2. 2. The option shall vest and become exercisable over a period of 36 months from the Vesting Start Date, March 1, 2021, with 1/3 vesting on the first anniversary of the Vesting Start Date and the remaining balance to vest on a monthy basis for a period of 24 months thereafter, such that the option will be fully vested 36 months from the Vesting Start Date, subject to the reporting person's continuous service with the Issuer on each such date.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ